Cimetropium bromide

Concise Prescribing Info
GI tract spasm.
Dosage/Direction for Use
Adult: PO 50 mg 2-3 times/day.
Prostatic enlargement, paralytic ileus or pyloric stenosis.
Special Precautions
Caution when used in patients with diarrhoea or fever. Thyrotoxicosis, heart failure and in cardiac surgery. Children, elderly. Not advisable for use in angle-closure glaucoma.
Adverse Reactions
Mouth dryness, reduced bronchial secretions, pupil dilatation with loss of accommodation and photophobia. Skin flushing and dryness, transient bradycardia followed by tachycardia, with palpitations and arrhythmias, and micturition difficulty, as well as reduction in tone and motility of the GI tract resulting in constipation.
Drug Interactions
Effects may be enhanced when used with drugs with antimuscarinic properties e.g. amantadine, some antihistamines, phenothiazines and TCAs. May antagonise the GI effects of cisapride, domperidone and metoclopramide.
CIMS Class
ATC Classification
A03BB05 - cimetropium bromide ; Belongs to the class of belladonna alkaloids, semisynthetic, quaternary ammonium compounds. Used in the treatment of functional gastrointestinal disorders.
Disclaimer: This information is independently developed by CIMS based on cimetropium bromide from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in